BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19797189)

  • 21. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH;
    Circulation; 2015 Dec; 132(22):e262-6. PubMed ID: 26621643
    [No Abstract]   [Full Text] [Related]  

  • 22. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE;
    Circulation; 2015 Dec; 132(22):e292-7. PubMed ID: 26621646
    [No Abstract]   [Full Text] [Related]  

  • 23. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Mitten MJ; Zipes DP; Maron BJ; Bryant WJ;
    Circulation; 2015 Dec; 132(22):e346-9. PubMed ID: 26621654
    [No Abstract]   [Full Text] [Related]  

  • 24. Reducing the risk of heart attack and stroke: the American Heart Association/American College of Cardiology prevention guidelines.
    Jessup M; Antman E
    Circulation; 2014 Aug; 130(6):e48-50. PubMed ID: 25092283
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical review and implications of the guideline for the early management of patients with acute ischemic stroke.
    Livesay SL
    AACN Adv Crit Care; 2014; 25(2):130-41. PubMed ID: 24752026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
    Kernan WN; Ovbiagele B; Black HR; Bravata DM; Chimowitz MI; Ezekowitz MD; Fang MC; Fisher M; Furie KL; Heck DV; Johnston SC; Kasner SE; Kittner SJ; Mitchell PH; Rich MW; Richardson D; Schwamm LH; Wilson JA;
    Stroke; 2014 Jul; 45(7):2160-236. PubMed ID: 24788967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteplase for stroke. American Heart Association explains how guidelines were formulated.
    Faxon D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092606
    [No Abstract]   [Full Text] [Related]  

  • 28. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
    Adams HP; del Zoppo G; Alberts MJ; Bhatt DL; Brass L; Furlan A; Grubb RL; Higashida RT; Jauch EC; Kidwell C; Lyden PD; Morgenstern LB; Qureshi AI; Rosenwasser RH; Scott PA; Wijdicks EF; ; ; ; ;
    Circulation; 2007 May; 115(20):e478-534. PubMed ID: 17515473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
    Adams HP; del Zoppo G; Alberts MJ; Bhatt DL; Brass L; Furlan A; Grubb RL; Higashida RT; Jauch EC; Kidwell C; Lyden PD; Morgenstern LB; Qureshi AI; Rosenwasser RH; Scott PA; Wijdicks EF; ; ; ; ;
    Stroke; 2007 May; 38(5):1655-711. PubMed ID: 17431204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.
    Goldberger JJ; Cain ME; Hohnloser SH; Kadish AH; Knight BP; Lauer MS; Maron BJ; Page RL; Passman RS; Siscovick D; Siscovick D; Stevenson WG; Zipes DP; ; ;
    Circulation; 2008 Sep; 118(14):1497-1518. PubMed ID: 18833586
    [No Abstract]   [Full Text] [Related]  

  • 31. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
    Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ;
    Circulation; 2015 Dec; 132(22):e310-4. PubMed ID: 26621649
    [No Abstract]   [Full Text] [Related]  

  • 32. 2024 AHA/ASA Performance and Quality Measures for Spontaneous Intracerebral Hemorrhage: A Report From the American Heart Association/American Stroke Association.
    Ruff IM; de Havenon A; Bergman DL; Dugue R; Frontera JA; Goldstein JN; Hemphill JC; Marulanda-Londono E; Prabhakaran S; Richards CT; Sunmonu NA; Vilar P; Wolfe SQ
    Stroke; 2024 Jul; 55(7):e199-e230. PubMed ID: 38695183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association.
    Sable C; Foster E; Uzark K; Bjornsen K; Canobbio MM; Connolly HM; Graham TP; Gurvitz MZ; Kovacs A; Meadows AK; Reid GJ; Reiss JG; Rosenbaum KN; Sagerman PJ; Saidi A; Schonberg R; Shah S; Tong E; Williams RG;
    Circulation; 2011 Apr; 123(13):1454-85. PubMed ID: 21357825
    [No Abstract]   [Full Text] [Related]  

  • 34. A radiologist's guide to the clinical scales used in the 2015 Endovascular Stroke Trials and the Revised American Heart Association/American Stroke Association Guidelines for Endovascular Stroke Treatment.
    Scheinfeld MH; Erdfarb AJ; Krieger DA; Bhupali D; Zampolin RL
    Emerg Radiol; 2016 Oct; 23(5):497-501. PubMed ID: 27389543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Black HR; Sica D; Ferdinand K; White WB;
    Circulation; 2015 Dec; 132(22):e298-302. PubMed ID: 26621647
    [No Abstract]   [Full Text] [Related]  

  • 36. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Harris KM; Thompson PD; Eichner ER; Steinberg MH;
    Circulation; 2015 Dec; 132(22):e343-5. PubMed ID: 26527715
    [No Abstract]   [Full Text] [Related]  

  • 37. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Wijdicks EF; Sheth KN; Carter BS; Greer DM; Kasner SE; Kimberly WT; Schwab S; Smith EE; Tamargo RJ; Wintermark M;
    Stroke; 2014 Apr; 45(4):1222-38. PubMed ID: 24481970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Estes NA; Kovacs RJ; Baggish AL; Myerburg RJ;
    Circulation; 2015 Dec; 132(22):e330-3. PubMed ID: 26621651
    [No Abstract]   [Full Text] [Related]  

  • 39. [Stroke unit: requirements for diagnostic imaging and interventions].
    Lang W
    Wien Med Wochenschr; 2001; 151(21-23):485-8. PubMed ID: 11762238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Link MS; Estes NA; Maron BJ;
    Circulation; 2015 Dec; 132(22):e339-42. PubMed ID: 26621653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.